Prevalence of age-related macular degeneration in the United States
- PMID: 15078675
- DOI: 10.1001/archopht.122.4.564
Prevalence of age-related macular degeneration in the United States
Erratum in
- Arch Ophthalmol. 2011 Sep;129(9):1188
Abstract
Objective: To estimate the prevalence and distribution of age-related macular degeneration (AMD) in the United States by age, race/ethnicity, and gender.
Methods: Summary prevalence estimates of drusen 125 microm or larger, neovascular AMD, and geographic atrophy were prepared separately for black and white persons in 5-year age intervals starting at 40 years. The estimated rates were based on a meta-analysis of recent population-based studies in the United States, Australia, and Europe. These rates were applied to 2000 US Census data and to projected US population figures for 2020 to estimate the number of the US population with drusen and AMD.
Results: The overall prevalence of neovascular AMD and/or geographic atrophy in the US population 40 years and older is estimated to be 1.47% (95% confidence interval, 1.38%-1.55%), with 1.75 million citizens having AMD. The prevalence of AMD increased dramatically with age, with more than 15% of the white women older than 80 years having neovascular AMD and/or geographic atrophy. More than 7 million individuals had drusen measuring 125 microm or larger and were, therefore, at substantial risk of developing AMD. Owing to the rapidly aging population, the number of persons having AMD will increase by 50% to 2.95 million in 2020. Age-related macular degeneration was far more prevalent among white than among black persons.
Conclusion: Age-related macular degeneration affects more than 1.75 million individuals in the United States. Owing to the rapid aging of the US population, this number will increase to almost 3 million by 2020.
Comment in
-
Age-related macular degeneration is the leading cause of blindness..JAMA. 2004 Apr 21;291(15):1900-1. doi: 10.1001/jama.291.15.1900. JAMA. 2004. PMID: 15108691 No abstract available.
Similar articles
-
Prevalence of open-angle glaucoma among adults in the United States.Arch Ophthalmol. 2004 Apr;122(4):532-8. doi: 10.1001/archopht.122.4.532. Arch Ophthalmol. 2004. PMID: 15078671 Free PMC article.
-
Causes and prevalence of visual impairment among adults in the United States.Arch Ophthalmol. 2004 Apr;122(4):477-85. doi: 10.1001/archopht.122.4.477. Arch Ophthalmol. 2004. PMID: 15078664
-
Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project.Arch Ophthalmol. 2008 Feb;126(2):241-5. doi: 10.1001/archophthalmol.2007.53. Arch Ophthalmol. 2008. PMID: 18268216
-
Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis.Ophthalmology. 2012 Mar;119(3):571-80. doi: 10.1016/j.ophtha.2011.09.027. Epub 2011 Dec 15. Ophthalmology. 2012. PMID: 22176800 Review.
-
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis.Am J Ophthalmol. 2015 Jul;160(1):85-93.e3. doi: 10.1016/j.ajo.2015.04.003. Epub 2015 Apr 6. Am J Ophthalmol. 2015. PMID: 25857680 Review.
Cited by
-
Toll-Like Receptor Signalling Pathways and the Pathogenesis of Retinal Diseases.Front Ophthalmol (Lausanne). 2022 Mar 31;2:850394. doi: 10.3389/fopht.2022.850394. eCollection 2022. Front Ophthalmol (Lausanne). 2022. PMID: 38983565 Free PMC article. Review.
-
Head mounted DMD based projection system for natural and prosthetic visual stimulation in freely moving rats.Sci Rep. 2016 Oct 12;6:34873. doi: 10.1038/srep34873. Sci Rep. 2016. PMID: 27731346 Free PMC article.
-
Optimising image quality with EyeMax Mono lens in dry age-related macular degeneration.Ir J Med Sci. 2023 Aug;192(4):1979-1986. doi: 10.1007/s11845-022-03151-2. Epub 2022 Sep 12. Ir J Med Sci. 2023. PMID: 36094732
-
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration.Biologics. 2020 Sep 11;14:83-94. doi: 10.2147/BTT.S252581. eCollection 2020. Biologics. 2020. PMID: 32982165 Free PMC article. Review.
-
Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.Curr Eye Res. 2013 Nov;38(11):1159-71. doi: 10.3109/02713683.2013.811257. Epub 2013 Jul 10. Curr Eye Res. 2013. PMID: 23841471 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical